IM Cannabis Corp. (IMCC) Stock
IM Cannabis stock price chart
IMCC stock quote & key statistics
IM Cannabis annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $54.7M | -$11.3M | — |
| FY2024 | $54.0M | -$10.6M | -$3.38 |
| FY2023 | $48.8M | -$9.5M | -$1.92 |
| FY2022 | $54.3M | -$188.9M | -$13.05 |
| FY2021 | $34.1M | -$17.8M | -$16.83 |
Fiscal year ending December 31. Source: company filings via EODHD.
About IM Cannabis Corp.
IM Cannabis Corp., headquartered in Tel Aviv-Yafo, Israel, specializes in the breeding, cultivation, and distribution of medical cannabis products across Israel, Germany, and Canada. The company is renowned for its diverse product offerings, including cannabis flowers and strain-specific extracts marketed under the IMC brand. Additionally, IM Cannabis Corp. provides a range of dried flowers, pre-rolls, and pressed hash products through its WAGNERS and Highland Grow brands, catering to both medical patients and adult-use recreational consumers.
With a commitment to quality and innovation in the cannabis industry, IM Cannabis Corp. leverages its expertise to meet the evolving needs of global markets. The company's strategic operations span cultivation, product development, and distribution channels, ensuring accessibility and reliability for consumers seeking therapeutic or recreational cannabis solutions. Through its comprehensive approach to cultivation and distribution, IM Cannabis Corp. aims to establish itself as a leader in the international cannabis market.
Founded on a mission to provide superior cannabis products backed by rigorous research and development, IM Cannabis Corp. contrinues to expand its presence and enhance its product portfolio. By focusing on regulatory compliance and sustainable growth strategies, the company remains dedicated to driving advancements in the medical and recreational cannabis sectors while delivering value to shareholders and stakeholders alike.
IM Cannabis stock FAQ
What is the IM Cannabis stock ticker symbol?
IM Cannabis Corp. trades on the NASDAQ under the ticker symbol IMCC.
What sector and industry is IM Cannabis in?
IM Cannabis Corp. is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.
How many employees does IM Cannabis have?
IM Cannabis Corp. has about 44 full-time employees.
What were IM Cannabis's revenue and earnings last fiscal year?
IM Cannabis reported revenue of $54.7M and net income of -$11.3M in fiscal 2025. Revenue grew 1.3% from the prior year.
When did IM Cannabis go public?
IM Cannabis stock began trading on May 20, 2020.
Drug Manufacturers - Specialty & Generic stocks
All Healthcare stocks →- ALKSAlkermes
- AMPHAmphastar Pharmaceuticals
- AMRXAmneal Pharmaceuticals
- ANIPANI Pharmaceuticals
- BCRXBioCryst Pharmaceuticals
- COLLCollegium Pharmaceutical
- EBSEmergent BioSolutions
- ELANElanco Animal Health
- EOLSEvolus
- HIMSHims & Hers Health
- INDVIndivior
- IRWDIronwood Pharmaceuticals
- KNSAKiniksa Pharmaceuticals
- LNTHLantheus
- NBIXNeurocrine Biosciences
- ORGOOrganogenesis
- PAHCPhibro Animal Health
- PBHPrestige Consumer Healthcare
- PCRXPacira BioSciences
- PRGOPerrigo
- SUPNSupernus Pharmaceuticals
- UTHRUnited Therapeutics
- VTRSViatris
- ZTSZoetis